医疗保健产品分销商汉瑞祥(Henry Schein)今日盘中股价大跌5.01%,引发市场关注。
汉瑞祥公布的2025财年指引显示,预计当年每股利润为4.80美元至4.94美元,增长幅度为1%至4%,低于分析师预期的4.99美元。此外,汉瑞祥预计2025财年总销售额较2024财年增长约2%至4%,也低于市场预期。
数据显示,持续通胀导致客户预算受到挤压,需求放缓是拖累汉瑞祥业绩的主因。由于较高的价格,客户不得不取消或推迟非紧急手术,如牙齿矫正和高端牙科修复等,影响了公司核心的牙科产品销售。汉瑞祥表示,虽然预计2025年牙科和医疗市场将略有改善,但仍低于预期,因而对业绩前景较为谨慎。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.